These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4768198)

  • 1. [Current problems of maximum INH chemotherapy of tuberculosis].
    Schwabe HK
    Med Monatsschr; 1973 Sep; 27(9):397-404. PubMed ID: 4768198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation].
    Bondarev IM; Dolgaia TM
    Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of decalcification in the treatment of tuberculosis. 8. Studies on the effect of decalcification on the course of tuberculosis caused by INH-resistant bacilli].
    Giza T; Hanicka M; Herman T; Jelonek A; Kurdzielewicz J; Rembiesowa H; Rudnik J; Wójciak W
    Gruzlica; 1968 Jun; 36(6):545-50. PubMed ID: 4970099
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental comparison of the tuberculostatic activities of INH, INHG and INHG-Na (author's transl)].
    Orlowski EH; Rosenfeld M; Wolter H; Schunk R
    Arzneimittelforschung; 1976; 26(3):409-16. PubMed ID: 989337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined application of mycobacteriophages and tubazid in experimental tuberculosis].
    Sharov GI; Gel'berg SI; Peschanskiĭ VS
    Probl Tuberk; 1974; (12):67-71. PubMed ID: 4445140
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
    Higuchi K; Harada N; Mori T
    Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Katiyar SK; Bihari S; Prakash S; Mamtani M; Kulkarni H
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):139-45. PubMed ID: 18230245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiacetazone and INH in tuberculosis. Synchronised peak concentration drug administration for greater action.
    Sen PK; Chatterjee R; Saha JR
    J Indian Med Assoc; 1973 Oct; 61(7):306-8. PubMed ID: 4129969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Mühlberger F; Nturanye F; Nasbimana J; Portaels F
    Pneumologie; 1995 Feb; 49(2):72-6. PubMed ID: 7724506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.